COMP <GO>
SONM vs CLRO // GROSS PROFIT MARGIN
DNA X Inc. (NASDAQ) VS. ClearOne Inc. (NASDAQ) • 15-METRIC TALLY: SONM 0
— CLRO 2
■ METRIC PARITY
LAST: $2.77 (-6.10%) • MKT CAP: $4.1M
gross-margins
—
LAST: $5.00 (-10.23%) • MKT CAP: $13.4M
gross-margins
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SONM VS. CLRO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SONM | CLRO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 1/9 | 1/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 34.4 | 56.1 | -21.70 | CLRO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.1M | $13.4M | -$9.3M | CLRO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SONM REV | CLRO REV | SONM GROSS % | CLRO GROSS % | SONM FCF | CLRO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $0 | — | — | -$23.5M | — |
| FY 2024 | $50.9M | $0 | 19.5% | — | -$8.7M | -$6.3M |
| FY 2023 | $93.6M | $0 | — | — | -$4.1M | $54.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SONM // BETA —
CLRO // BETA —